Skip to main content
. 2023 May 19;5(3):fcad159. doi: 10.1093/braincomms/fcad159

Figure 3.

Figure 3

Comparison of core cerebrospinal fluid biomarker levels. Comparison of assay-specific differences of means (DoM) with 95% confidence intervals (CI) from crude CSF biomarker levels in relation to HC as a reference. DoM of patients with CAA was compared to all controls by Mann–Whitney U-test. Abbreviations: Aβ, β-amyloid; CAA, cerebral amyloid angiopathy; HC, Healthy controls; MCI, mild cognitive impairment; Alzheimer’s disease-MCI, mild cognitive impairment due to Alzheimer’s disease